Figure 4
Figure 4. Absence of repopulating lymphocytes during nonresolving inflammation. (A) Zymosan was injected into the peritoneal cavity of pg91phox knockout mice, which, when compared with controls, showed a more aggressive inflammatory response that failed to resolve. (B) FACS analysis of cell types present during resolution revealed a progressive repopulation of lymphocytes during resolution that was lower in pg91phox knockout mice. (C) Lymphocytes obtained from the resolution phase (72 hours) of normal strain-matched wild-type controls and comprising B1 cells, NK cells, and γ/δ T cells, as well as CD4+/CD25+ cells, were transferred back into the peritoneal cavity of gp91phox knockout mice (72 hours) and subsequently challenged, intraperitoneally, with LPS. Inflammation was reduced in gp91phox knockout mice that received resolution-phase lymphocytes compared with gp91phox mice alone. *P ≤ .05; **P ≤ .01 as determined by ANOVA, followed by Bonferroni t test, with data expressed as means plus or minus SEM.

Absence of repopulating lymphocytes during nonresolving inflammation. (A) Zymosan was injected into the peritoneal cavity of pg91phox knockout mice, which, when compared with controls, showed a more aggressive inflammatory response that failed to resolve. (B) FACS analysis of cell types present during resolution revealed a progressive repopulation of lymphocytes during resolution that was lower in pg91phox knockout mice. (C) Lymphocytes obtained from the resolution phase (72 hours) of normal strain-matched wild-type controls and comprising B1 cells, NK cells, and γ/δ T cells, as well as CD4+/CD25+ cells, were transferred back into the peritoneal cavity of gp91phox knockout mice (72 hours) and subsequently challenged, intraperitoneally, with LPS. Inflammation was reduced in gp91phox knockout mice that received resolution-phase lymphocytes compared with gp91phox mice alone. *P ≤ .05; **P ≤ .01 as determined by ANOVA, followed by Bonferroni t test, with data expressed as means plus or minus SEM.

Close Modal

or Create an Account

Close Modal
Close Modal